UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038997
Receipt number R000044313
Scientific Title Development of a minimally invasive, ultra-sensitive rapid diagnosis kit for influenza virus
Date of disclosure of the study information 2020/05/31
Last modified on 2019/12/25 17:46:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Development of a minimally invasive, ultra-sensitive rapid diagnosis kit for influenza virus

Acronym

Development of rapid diagnosis kit for influenza virus

Scientific Title

Development of a minimally invasive, ultra-sensitive rapid diagnosis kit for influenza virus

Scientific Title:Acronym

Development of rapid diagnosis kit for influenza virus

Region

Japan


Condition

Condition

Influenza virus infection

Classification by specialty

Medicine in general Infectious disease Laboratory medicine
Emergency medicine Adult Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Comparison of diagnostic accuracy by inspection method and site for influenza virus infection

Basic objectives2

Others

Basic objectives -Others

Survey of thresholds and conditions for influenza virus infection

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Diagnostic accuracy for each specimen collection site and test method

Key secondary outcomes

Onset threshold of influenza virus infection


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Sampling of oral mucosa, pharyngeal abrasion, nasopharyngeal swabs, nasal discharge, and saliva of patients and healthy people with dense contact

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients visited for complaints of influenza-like symptoms in an influenza virus infection endemic area, and its rich contact healthy people

Key exclusion criteria

nothing

Target sample size

400


Research contact person

Name of lead principal investigator

1st name kazuhito
Middle name
Last name tabata

Organization

University of Tokyo

Division name

Noji Laboratory, Department of Applied Chemistry

Zip code

113-8656

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-5841-1872

Email

kazuhito@nojilab.t.u-tokyo.ac.jp


Public contact

Name of contact person

1st name Hironobu
Middle name
Last name Kamagata

Organization

University of Tokyo

Division name

Noji Laboratory, Department of Applied Chemistry

Zip code

113-8656

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

TEL

03-5841-1872

Homepage URL


Email

kamagatahrn1981@gmail.com


Sponsor or person

Institute

University of Tokyo

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

School of Engeneering, University of Tokyo

Address

7-3-1 Hongo, Bunkyo-ku, Tokyo

Tel

03-5841-8824

Email

anzen@anzen.t.u-tokyo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

うちだ内科医院(東京都)
本郷耳鼻咽喉科クリニック(東京都)
道東の森総合病院(北海道〉
武蔵ヶ丘病院(熊本県)
葛が谷つばさクリニック(神奈川県)


Other administrative information

Date of disclosure of the study information

2020 Year 05 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 02 Month 15 Day

Date of IRB

2019 Year 02 Month 15 Day

Anticipated trial start date

2019 Year 12 Month 11 Day

Last follow-up date

2020 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 12 Month 25 Day

Last modified on

2019 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000044313


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name